Powered by: Motilal Oswal
2025-06-13 09:42:51 am | Source: Accord Fintech
Anupam Rasayan inches up on signing master purchase agreement with Japanese Multinational Conglomerate
Anupam Rasayan inches up on signing master purchase agreement with Japanese Multinational Conglomerate

Anupam Rasayan India is currently trading at Rs. 1105.10, up by 1.45 points or 0.13% from its previous closing of Rs. 1103.65 on the BSE.  

The scrip opened at Rs. 1090.10 and has touched a high and low of Rs. 1107.40 and Rs. 1086.65 respectively. So far 556 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 1151.00 on 12-Jun-2025 and a 52 week low of Rs. 600.95 on 28-Feb-2025.

Last one week high and low of the scrip stood at Rs. 1151.00 and Rs. 1045.00 respectively. The current market cap of the company is Rs. 12132.57 crore.

The promoters holding in the company stood at 61.18%, while Institutions and Non-Institutions held 8.71% and 30.11% respectively.

Anupam Rasayan India has signed a long-term master purchase agreement (MPA) with Japan-based Multinational Conglomerate., a global leader in fluorochemicals and advanced technology solutions. This long-term partnership underscores MNC confidence in Anupam’s expertise and positions Anupam as a key supplier in high-growth market segments.

The agreement establishes comprehensive terms governing the customer’s purchase of specialty chemicals from Anupam Rasayan, marking a significant milestone in Anupam’s strategic expansion into the Japanese market.

Anupam Rasayan India is one of the leading companies engaged in the custom synthesis (CSM) and manufacturing of specialty chemicals in India.

Disclaimer: The content of this article is for informational purposes only and should not be considered financial or investment advice. Investments in financial markets are subject to market risks, and past performance is not indicative of future results. Readers are strongly advised to consult a licensed financial expert or advisor for tailored advice before making any investment decisions. The data and information presented in this article may not be accurate, comprehensive, or up-to-date. Readers should not rely solely on the content of this article for any current or future financial references. To Read Complete Disclaimer Click Here